6505--Supply, Nuclear Medicine Isotopes - Radiology - B+4, Chillicothe
ID: 36C25024Q0030Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF250-NETWORK CONTRACT OFFICE 10 (36C250)DAYTON, OH, 45428, USA

PSC

DRUGS AND BIOLOGICALS (6505)
Timeline
  1. 1
    Posted Oct 5, 2023 4:46 PM
  2. 2
    Updated Oct 5, 2023 4:46 PM
  3. 3
    Due Oct 12, 2023 1:00 PM
Description

Sources Sought Notice: VETERANS AFFAIRS, DEPARTMENT OF is seeking suppliers for the procurement of Radiopharmaceuticals and associated supplies for the Chillicothe VA Medical Center in Chillicothe, Ohio. This is necessary to continue the current standard of care for Nuclear Medicine patients at the medical center. The scope of the project is to procure Radiopharmaceutical Isotopes and deliver them to the Chillicothe VA Medical Center. The vendor will be responsible for routine delivery and pick-up of Radiopharmaceutical items during specified hours. The contract will have a performance period of twelve months with four one-year option periods. The delivery schedule will be determined after the contract is awarded. Interested vendors should respond to the notice by 09:00 AM EST on October 12, 2020, via email to percy.johnson2@va.gov.

Point(s) of Contact
Percy JohnsonContract Specialist
(614) 257-5534
percy.johnson2@va.gov
Files
Title
Posted
3/26/2024
Lifecycle
Title
Type
Similar Opportunities
6505--PET MRI Radiopharmaceuticals - Detroit VAMC
Active
Veterans Affairs, Department Of
The Department of Veterans Affairs is seeking experienced contractors for a potential five-year IDIQ contract to supply PET MRI Radiopharmaceuticals to the John D. Dingell VA Medical Center in Detroit, Michigan. The goal is to ensure a steady supply of these specialized pharmaceuticals to enhance the center's medical capabilities. ## Opportunity Overview This sources sought notice is issued for market research purposes to gauge interest and capability in meeting the VA Medical Center's requirements. The center requires a reliable supply of a range of PET radiopharmaceuticals, including Cu64 Dotatate, F18 PSMA, F18 FDG, and F18 Vizamyl, for medical purposes. ## Scope of Work The selected contractor will be responsible for fulfilling orders of these pharmaceuticals, ensuring timely deliveries, and adhering to strict quality control measures. They must employ registered radio-pharmacists and provide a trouble-shooter to assist with any issues. Additionally, the contractor must manage waste products disposal and comply with regulations regarding shipping and handling. ## Schedule of Supplies - Cu64 Dotatate: 3-5 mCi Each, 10 doses annually - F18 PSMA: 8-10 mCi Each, 52 doses annually - F18 FDG: 8-10 mCi Each, 780 doses annually - F18 Vizamyl/F18 Neuraceq/F18 Amyvid: 8-10 mCi Each, 52 doses annually ## Eligibility Criteria This opportunity is open to businesses capable of meeting the stringent requirements for handling and supplying these specialized pharmaceuticals. Registration in the System for Award Management (SAM) is mandatory. Contractors claiming small business preferences must meet relevant FAR guidelines and register with the SBA. ## Funding and Contract Details Funding for this contract is estimated at approximately $1.5 million over the five-year period. The contract type is an IDIQ contract with a potential ordering period from October 1, 2024, to September 30, 2029. ## Submission Process Interested parties should provide a response to the Contracting Officer, Jeffrey Rozema, via email by the deadline. The email should include: - Business Name and Address - Point of Contact Details - SAM Unique Entity ID - Type of Small Business, if applicable - A detailed description of the company's ability to meet the requirements, including facility locations and relevant experience. ## Evaluation Criteria Responses will be evaluated based on the extent to which they demonstrate an ability to meet the stated requirements. The VA will select vendors capable of providing a reliable supply of the required pharmaceuticals under the specified conditions. ## Contact Information For clarification or further information, interested parties can contact Jeffrey Rozema, Contracting Officer, via email at jeffrey.rozema@va.gov or by phone at 269-966-5600 ext. 36450. The government encourages interested parties to respond, as this is a sources sought notice to gauge interest and capability.
6505--VA Loma Linda Radiopharmaceuticals
Active
Veterans Affairs, Department Of
The Department of Veterans Affairs, Department of Veterans Affairs, is seeking radiopharmaceuticals for the VA Loma Linda Healthcare System in Loma Linda, CA. Radiopharmaceuticals are used in nuclear medicine and imaging services for diagnostic and therapeutic purposes. The procurement includes various types and quantities of radiopharmaceuticals to be delivered over a base period and four option years. The contractor must be an authorized dealer, distributor, or reseller of original equipment manufacturer (OEM) products. The period of performance is from October 1, 2024, to September 30, 2029. The estimated quantities provided in the solicitation are not contractual and the government will only pay for the quantities actually ordered. The pricing shall be firm fixed-price and the minimum order is $30,000.00. The solicitation will be conducted in accordance with FAR Part 12, Part 13, Subpart 16.5, and Part 19. Offerors must submit their responses by July 22, 2024, and must be registered in www.sam.gov to do business with the government.
6505--Plyarify - Radiopharmaceuticals
Active
Veterans Affairs, Department Of
Special Notice: VETERANS AFFAIRS, DEPARTMENT OF is seeking to procure Plyarify - Radiopharmaceuticals. Plyarify is a radioactive diagnostic agent used for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. The procurement involves the preparation and delivery of F-18 Piflufolastat (Pylarify) doses performed at a contractor facility and delivered to the PET/CT Service at VA Connecticut Healthcare in West Haven, CT. Deliveries will be made Monday through Friday between 7:00 am and 3:00 pm. Only vendors within a 60-mile radius of VA Connecticut need to respond to this RFQ. The contractor's personnel must be licensed in a State, Territory, or Commonwealth of the United States or the District of Columbia. The contractor will bill on a monthly basis, itemizing all services rendered. The services covered by this contract shall be furnished by the contractor Monday through Friday, 7:00 am - 3:00 pm. There is no restriction on the number of orders or deliveries required per day. The delivery location is VA Connecticut Healthcare System in West Haven, CT. Interested parties must submit their capability to fulfill the requirement in writing by Monday, July 15, 2024, at 12 pm EST time.
Solicitation-Radiopharmaceuticals -Evans Army Community Hospital
Active
Dept Of Defense
The Evans Army Community Hospital in Fort Carson, Colorado, is seeking radiopharmaceuticals through a federal contract. The main purpose of this solicitation, W81K00-24-Q-0167, is to obtain these specialized pharmaceuticals for the hospital's needs. ## Scope of Work The successful awardee will be responsible for supplying radiopharmaceuticals as outlined in the attached Statement of Work (SOW). The SOW details the specific requirements and expectations, including the delivery of a comprehensive range of radiopharmaceuticals. Awardees will need to provide pricing information for the products listed in the attached RPH Product List. ## Eligibility Criteria Eligible applicants for this opportunity should have expertise and experience in the pharmaceutical industry, specifically in manufacturing and supplying radiopharmaceuticals. The ability to comply with the specific requirements outlined in the SOW and meet the pricing expectations is crucial. ## Funding and Contract Details The contract type is not specified in the provided information. However, the notice emphasizes the importance of reviewing the relevant FAR (Federal Acquisition Regulation) addenda for instructions and evaluation criteria. The estimated funding for this contract is not available in the provided information. ## Submission Process Offerors are required to submit their questions by email, with a copy to both the primary and secondary contact, by the deadline of 10:00 AM (Mountain) on July 31, 2024. The submissions should refer to the attached documents, specifically the SOW and RPH Product List, when crafting their proposals. ## Evaluation Criteria The evaluation of offers will be based on the guidelines outlined in the FAR 52.212-1 and FAR 52.212-2 addenda. The specific evaluation criteria are not provided in the information supplied, but typically include factors such as price, technical merit, and past performance. ## Contact Information For any questions or clarifications, offerors should contact the primary contact, Fabiola Palma-Trujillo, via email at fabiola.palma-trujillo.civ@health.mil. Ms. Robyn Villafranco should also be copied on all communications (email: Robyn.A.Villafranco.civ@health.mil). Please note that the above summary is based on the information provided and may not cover all the nuances of the opportunity. For a comprehensive understanding, carefully review the attached documents referenced in the opportunity listing.
6525--Sources Sought | REMOVAL OF RADIOACTIVE MATERIALS-688 |
Active
Veterans Affairs, Department Of
Sources Sought VETERANS AFFAIRS, DEPARTMENT OF is seeking companies capable of providing radioactive waste material removal services at the DC Veterans Affairs Medical Center in Washington, D.C. The contractor will be responsible for packing, transporting, and disposing of sealed sources from the Nuclear Medicine Section, Radiology Service. Interested companies are requested to provide their business information, capability statement, previous experience, GSA contract number (if applicable), and a ballpark cost estimate. Responses must be submitted by July 17, 2024, via email to timothy.russell@va.gov. This notice is for planning purposes only and will assist in the development of the requirement and acquisition strategy.